NCT03783871View on ClinicalTrials.gov

NeuWave Microwave Ablation HCC China Study

NACompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

February 18, 2019

Primary Completion Date

January 17, 2024

Study Completion Date

January 17, 2024

Conditions
Liver TumorHepatocellular Carcinoma
Interventions
DEVICE

Microwave ablation

Subjects will be treated with microwave ablation.

Trial Locations (4)

100089

Chinese PLA General Hospital, Beijing

200120

Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

510000

Sun Yat-sen University Cancer Center, Guangzhou

The First Affiliated Hospital，Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Ethicon, Inc.

INDUSTRY

NCT03783871 - NeuWave Microwave Ablation HCC China Study | Biotech Hunter | Biotech Hunter